GlobeNewswire
-
Press Release: Sanofi’s Infilbray approved in the US as the first medicine to treat neurological manifestations of Type 3 Gaucher disease
18/11/2026 -
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18/11/2026 -
Pyxis Oncology to Host Live Webcast on Updated MICVO Phase 1 Monotherapy Data Demonstrating Durable Response in 2L+ R/M HNSCC Following Late-Breaking Oral Presentation at EORTC-NCI-AACR Symposium
19/11/2026 -
Livsayis™ (cemdisiran) Approved by the FDA as First and Only siRNA Therapy in Generalized Myasthenia Gravis and Only Treatment with Four-Times-a-Year Subcutaneous Dosing
19/11/2026 -
Rosedil Introduces Rosedil Capsules, a Biotin, Zinc and Horsetail Dietary Supplement for Hair Wellness Routines
19/11/2026 -
HUTCHMED Highlights HMPL-A830 Pre-Clinical Data Presented at the 38th EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
19/11/2026 -
Immutep Reports Encouraging Disease-Free Survival from EFTISARC-NEO Phase II Trial in Soft Tissue Sarcoma
19/11/2026 -
Tevogen Highlights Significant Liability Reduction and Continued Insider Control
18/11/2026 -
Grant of Restricted Stock Units and Warrants to Employees in Genmab
18/11/2026 -
Lakefront Creates New Subscription Right Plan
18/11/2026 -
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
18/11/2026 -
PROCEPT BioRobotics® to Participate in the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026
18/11/2026 -
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/11/2026 -
BillionToOne Responds to Inaccurate and Misleading Short Seller Report
18/11/2026 -
InnovAge Holding Corp. Resolves Civil Matter with U.S. Department of Justice & Participating States
18/11/2026 -
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/11/2026 -
ProKidney Names Farah Ali, M.D., M.S., Chief Medical Officer
18/11/2026 -
Commure Ranked No. 1 for Provider Satisfaction in KLAS 2026 Top 20 Report
18/11/2026 -
New Three-Year Real-World LEQEMBI® Data Presented at CTAD 2026
18/11/2026
Pages